Samtidig behandling med stoffer, der øger gastrisk pH, bør undgås, idet opløseligheden og absorptionen af lapatinib kan reduceres.
Concomitant treatment with substances that increase gastric pH should be avoided, as lapatinib solubility and absorption may decrease.